Development of Analytical Method for Detection of Some Pharmaceuticals in Surface Water
Abstract
Purpose: To develop and validate a simple method using solid – phase extraction along with liquid chromatography–time of flight mass spectrometry for the analysis of pharmaceuticals in surface water of Tangkas River, Malaysia.
Methods: Liquid chromatography (LC) was performed on a Dionex Ultimate 3000/LC 09115047 (USA) system equipped with a vacuum degasser, a quaternary pump, an autosampler and UV-Vis diod array detector. Chromatography was performed on a Thermo Scientific C18 (250 mm x 2.1 mm, i.d.: 5μm) column. The injection volume was 20 μL. All compounds (hydrochlorothiazide, gliclazide, diclofenac-Na and mefenamic acid) were analysed in negative ion (NI) mode and eluted off the column with a mobile phase consisting of (A) 0.1% formic acid (FA) in deionised water (DIW) and (B) 40% acetonitrile (ACN) in methanol (MeOH) at 0.3 ml/min. Mass spectrometry was performed on a time of flight (TOF) instrument.
Results: The linearity range, 5 - 500 ng/mL, provided a determination coefficient (R2) > 0.99 for all compounds. The limit of detection (LOD) ranged from 65 - 136 ng/L while recovery ranged from 45 - 111.2 % in the river water. Two pharmaceutical compounds were detected in the surface water samples: diclofenac sodium and mefenamic acid at concentrations of 340 and 545 ng/L, respectively.
Conclusion: The developed method is linear in the range 5 - 500 ng/mL, and precise and acceptable recoveries were obtained. In addition, this method is suitable to identify and quantify trace concentrations of diclofenac sodium and mefenamic acid in surface water.
Keywords: Diclofenac, Mefenamic acid, Electrospray Ionization, Mass spectrometry, Solid phase extraction (SPE), Tangkas river, Collision energy.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
